Gastrointestinal Cancer News

Use of immune checkpoint inhibitors for pregnant women with cancer may be safer than previously thought, according to study results published in JAMA Network Open.

A consortium recommended classifying people with a high risk for pancreatic cancer into subtypes based on family history and germline variants, according to findings published in Journal of the National Comprehensive Cancer Network.

Researchers are launching an all-telehealth precision oncology trial that will include patients with pancreatic cancer whose tumors have the same genetic mutation.

Researchers estimated that nearly 60 million individuals aged 45 to 85 years are at average-risk for colorectal cancer and eligible for screening in the U.S., according to cross-sectional study data in JAMA Network Open.

The addition of durvalumab to chemotherapy doubled 3-year survival among patients with advanced biliary tract cancers, according to data released by the agent’s manufacturer.

Detection of colorectal cancer was “rare” at surveillance colonoscopy among patients aged 70 to 85 years, and although detection of advanced neoplasia was higher, overall yields did not increase significantly with age, researchers reported.

Matt Kalaycio, MD, FACP, has been elected chair of National Comprehensive Cancer Network’s board of directors.

Treatment for Helicobacter pylori was associated with improved overall and disease-free survival among patients with confirmed infection and gastric cancer who underwent gastrectomy, according to data published in JAMA Network Open.

Triennial blood-based screening for colorectal cancer was not cost-effective compared with existing screening modalities such as colonoscopy, fecal immunochemical test and stool DNA testing, according to microsimulation model projections.

An investigational exosome-based liquid biopsy showed better than 90% accuracy for detecting early-stage pancreatic cancer among U.S.-based participants in a prospective multicenter study.